Navigation Links
Personalized Medicine for Mental Illness on the Horizon
Date:5/1/2009

WASHINGTON, May 1 /PRNewswire-USNewswire/ -- New advances in research on brain disorders offer the promise of more personalized treatment for individuals suffering from mental illnesses, according to scientists addressing the first Domenici Neuroscience Symposium in Washington today.

The symposium featured scientists from such leading neurodiagnostic facilities as the Mind Research Network (MRN), the National Institute of Mental Health (NIMH), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA), and Harvard University. The researchers presented their enterprising approaches to unlocking the puzzles of schizophrenia and addictive disorders.

"We are making significant progress in identifying complex biomarkers for schizophrenia and addiction," said Dr. Kent Hutchison, MRN Chief Science Officer.

"We expect this research to accelerate and translate into clinical applications, and eventually provide personalized medicine for people with mental illness."

MRN presented the Domenici Neuroscience Symposium, held in honor of MRN's founder, retired U.S. Senator Pete Domenici of New Mexico, who established MRN in Albuquerque in 1998. The Senator envisioned a collaborative research effort to advance brain imaging and genetics techniques that could aid diagnoses and treatment of brain disorders.

"Today's symposium brought together MRN, NIMH, NIAAA, and NIDA both as a tribute to the scientific accomplishments inspired by the Senator, and to present new methods for treating and diagnosing mental illness and brain disease," said MRN President and CEO Dr. John Rasure.

Symposium presentations focused on how neuroimaging, genetics, and computer science are speeding discovery about brain disorders. Progress is being made with use of more sophisticated imaging equipment, novel ways to use existing imaging techniques, and less expensive genetic testing.

"I believe MRN and the other symposium scientists are going to produce incredible results in my lifetime," Senator Domenici predicted. "Equally important, I am optimistic and hopeful that more accurate diagnosis and treatment will help erase the stigma millions of people now face because of mental illness."

MRN and NIMH intend to make the Domenici Neuroscience Symposium a yearly conference for researchers and others focused on brain disorders to come together and discuss how to find better outcomes for individuals and families looking for triumph over brain disease and injury.

"NIMH is committed to working collaboratively to close the gap between basic biological knowledge and effective mental health care -- paving the way for prevention, recovery, and treatment," said Tom Insel, MD, Director of the NIMH.


'/>"/>
SOURCE Mind Research Network
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mayo Clinic and Microsoft Deliver a Powerful and Personalized Consumer Solution for Managing Health
2. Ocean Cosmetic Medicine of Santa Monica Has Created Something New: Personalized Boutique Style Aesthetic Treatments
3. Frost & Sullivan Recognizes CRi for Innovations Leading to Personalized Medicine
4. Chicago-area ASBS Bariatric Surgery Center of Excellence Provides Personalized Care Like No Other Weight-Loss Surgery Program
5. Personalized genome sequencing reveals coding error in gene for inherited pancreatic cancer
6. Adena Shoulder Surgeon Blends Innovative Techniques with Personalized Patient Care
7. Investing in personalized medicine will benefit Canada
8. UCLA scientists develop crystal ball for personalized cancer treatment
9. One Million Americans Now Receive Personalized FDA Drug Safety Alerts Through iGuard.org
10. Nutrigenomics - Developing Personalized Diets for Disease Prevention - Is the Focus of a Special Issue of OMICS
11. Rochester Shoulder Surgeon Blends Innovative Techniques with Personalized Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... combining seaweeds, botanicals and 100 percent pure essential oils, announced the company had a ... Head, SC. , The annual ECRM event gives companies that work in the nutritional, ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... ... Angel”: a heartwarming and earnest tale of faith and believing in the path ... the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of The ... of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, but ...
(Date:1/20/2017)... ... 2017 , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true ... mother of three in Oklahoma City, and a devoted woman of faith. , “Becoming ... been in the back of my mind for years, but actually doing it might have ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Management System: an On-demand E-learning system for Clinical and Regulatory education for ... is based on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Jan. 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ... mitochondrial dysfunction, today announced new additions to its senior ... Chief Medical Officer, and Daniel Geffken as ... Jim Carr , Pharm.D. has been promoted to ... pleased to welcome Doug and Daniel to our management ...
(Date:1/19/2017)... CITY, Calif. , Jan. 19, 2017  Abaxis, ... company manufacturing point-of-care blood analysis instruments and consumables for ... conference call to discuss its financial results for the ... The call will be at 4:15 p.m. ET on ... results for the third quarter fiscal year 2017 after ...
(Date:1/19/2017)... LEXINGTON, Massachusetts , January 19, 2017 ... SHPG ) announced that the U.S. Food and Drug ... resubmission of a New Drug Application (NDA) for SHP465, ... being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity ... decision on or around June 20, 2017, the designated ...
Breaking Medicine Technology: